SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-037643
Filing Date
2024-03-28
Accepted
2024-03-28 08:35:12
Documents
12
Period of Report
2024-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atra-20240328.htm   iXBRL 8-K 42577
2 EX-99.1 atra-ex99_1.htm EX-99.1 279389
  Complete submission text file 0000950170-24-037643.txt   456419

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atra-20240328.xsd EX-101.SCH 26006
15 EXTRACTED XBRL INSTANCE DOCUMENT atra-20240328_htm.xml XML 4892
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 24793716
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)